You're watching...
FBN’s Robert Gray on Carl Icahn suing Amylin for more time to nominate directors to help pressure the company to accept a takeover bid.
Also in this playlist...
Auto-advance: ON
Auto-advance
This transcript is automatically generated
I'm Robert -- -- -- Fox Business brief.
The CBOE's volatility index doesn't fix up for a seventh straight day it's the longest streak of gains and eight and a half years.
This is the major stock averages retreat from multi year highs.
Now the index is a widely followed gage of investor anxiety rises as investors buy put options as downside protection for their long positions in stocks.
FaceBook meanwhile as buying photo sharing software company -- to grant the price tag one billion dollars in cash and stock.
FaceBook founder and CEO Mark Zuckerberg who posted the news on his own time line.
And Amylin Pharmaceuticals is being sued by one of its investors Carl Icahn says he's suing them.
For more time to nominate directors it might help put pressure on Amylin to accept a takeover bid.
-- -- -- the diabetes drug maker for rejecting the roughly three and a half billion dollar -- ever -- from Bristol-Myers Squibb.
Icahn has a roughly 9% stake in.
